The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Jörg Latus, MD
The Future of IgAN Care
An De Vriese, MD, PhD
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Itching for Answers: Holistic CKD-aP Care
Reading Between the Lines: What PROMs Reveal About Itch
What You Don’t See: A Patient’s View of Living with CKD-aP
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
Sayna Norouzi, MD
Extra Innings – Sustaining Victory Beyond the First Game
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
Turning the Double Play – Comprehensive Secondary Prevention
Crossing Home Plate – Building a Winning Team Culture
Leadoff Hitter – Spotting High-Risk Players
Swing for the Fences – LDL-C as the Power Hitter
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Claudia Seikrit, MD